Portfolio Company · Operating Co.
Company Snapshot
Molecular Products is a healthcare portfolio company held by Arlington Capital Partners, with parent firm headquartered in Washington, DC, United States. Profile compiled from public sources; submit updates to extend the public record.
Ownership Context
Molecular Products is a former portfolio company of Arlington Capital Partners, headquartered in Washington, DC, United States. Public coverage of this company is grouped under its parent firm's profile.
Sources
www.arlingtoncap.com/investmentsThis profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Molecular Products and does not provide investment advice.
Other portfolio companies of Arlington Capital Partners
Afton Scientific
Healthcare
AV
Aerospace & Defense
AV (AeroVironment)
Aerospace & Defense
AVS Bio
Healthcare
BlueHalo
Aerospace & Defense
CBSET
Healthcare
Centauri
Government Services & Technology
Cordica Medical
Healthcare
See the full Arlington Capital Partners portfolio.
Other Healthcare portfolio companies
123Dentist
via kkr
A Place for Mom
via warburg pincus
A-S Medication Solutions (ASMS)
via warburg pincus
AA Medical Health
via warburg pincus
Abacus Pharmaceuticals
via carlyle group
Abacus Pharmaceuticals
via the carlyle group
Abbisko
via the carlyle group
Abbisko
via carlyle group
Browse all PE-backed companies.